SCHEMBL14448152

SCHEMBL14448152

Cc1ccc(NC(=O)NC(C)(C)C)cc1NC(=O)NC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.56
▸ NPC1 O15118 5/20 0.56
▸ RAB9A P51151 5/20 0.56
▸ MEN1 O00255 4/20 0.56
▸ ALDH1A1 P00352 4/20 0.55
▸ KDM4E B2RXH2 3/20 0.55
▸ HTT P42858 3/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ TP53 P04637 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ CASP1 P29466 1/20 0.55
▸ CASP7 P55210 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ MAPT P10636 6/20 0.55
▸ LMNA P02545 3/20 0.55
▸ ATM Q13315 1/20 0.55
▸ DDX3X O00571 1/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.48
▸ POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12846792 0.82 LMNA (0.56) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL13411694 0.81 MAPT (0.59) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL21116141 0.81 CASR (0.56) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL13756247 0.80 RAB9A (0.81) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL16884951 0.80 AR (0.57) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL10330604 0.79 MAPT (0.57) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL12553557 0.79 LMNA (0.47) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL12360776 0.79 MAPT (0.42) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL12553567 0.79 LMNA (0.47) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL12360775 0.79 MAPT (0.42) KMT2ANPC1RAB9AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070160635-A1 Cosmetic composition textured with a specific asymmetric bis-urea derivative L'OREAL (FR) 2007-07-12 — — US disclosed
US-20070160635-A1 Cosmetic composition textured with a specific asymmetric bis-urea derivative L'OREAL (FR) 2007-07-12 — — US disclosed
EP-1797864-A1 Cosmetic composition textured by a specific asymmetric bis-urea derivative L'OREAL (FR) 2007-06-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070160635-A1 Cosmetic composition textured with a specific asymmetric bis-urea derivative FHIT, CUTA, FABP4 KMT2A 2006/4885NPC1 2213/4885RAB9A 2969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback